Jake Fehling is an exceptional marketing leader whose strategic vision has propelled Movement Mortgage to become one of the fastest-growing mortgage lenders in the U.S. His innovative launch of the ...
New subcutaneous autoinjector offers at-home treatment option for patients Eisai and Biogen have announced FDA approval of LEQEMBI IQLIK (lecanemab-irmb) for maintenance dosing in early Alzheimer’s ...
As emerging pathogens and rare diseases continue to test global health systems, innovative diagnostic reagents are transforming how we detect, differentiate, and respond to complex conditions. A ...
With heavy hearts, we announce that Linda Fehling returned to the Lord on August 21, 2025. Linda Marian Winters Fehling was born on June 4, 1954, in Marietta, Ohio, to Alberta Margaret Ott and ...
Abstract: Point cloud registration is a common step in many 3D computer vision tasks such as object pose estimation, where a 3D model is aligned to an observation. Classical registration methods ...
SHANGHAI, Aug 14 (Reuters) - Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local manufacturers, industry ...
A Massachusetts biotech working on a class of medicines called "circular RNA therapeutics" has been named the world's No. 1 most innovative startup. Vertex Pharmaceuticals drops pain drug, shares sink ...
Abstract: The reagent addition control level of the zinc first rougher has a significant impact on the quality of the zinc concentrate. As froth visual features are important indicators of working ...
In 1997 I went off to college, at an East Coast Jesuit school where everyone was really into athletics. The other students liked to drink and party, but no one really cared about the rave scene except ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results